Remote Patient Monitoring Systems

Remote Patient Monitoring Systems - Global Strategic Business Report

Global Industry Analysts, Date of Publication: Sep 18, 2015, 273 Pages
US$4,500.00
GIA-MCP7076

Remote Patient Monitoring Systems

The global market for Remote Patient Monitoring Systems (RPM) is projected to reach US$46 billion by 2020, driven by government measures to reduce healthcare spending against a backdrop of widening healthcare budget deficit. The growth in the market is also driven by the shift of the healthcare industry towards an outcome-driven effective healthcare system. Encouraged by the widespread proliferation of high-speed Internet, and related services, adoption of RPM systems is witnessing strong growth. The United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 13% over the analysis period. The growth in the region is driven by the increase in per capita healthcare spending and the need for a cost-effective and sustainable healthcare system and infrastructure capable of addressing the growing healthcare needs of an expanding population.

This report analyzes the worldwide markets for Remote Patient Monitoring Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 83 companies including many key and niche players such as -

Abbott Laboratories
Aerotel Medical Systems
AMD Global Telemedicine, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation

TABLE OF CONTENTS

 I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

      Study Reliability and Reporting Limitations                       I-1
      Disclaimers                                                       I-2
      Data Interpretation & Reporting Level                             I-2
       Quantitative Techniques & Analytics                              I-3
      Product Definitions and Scope of Study                            I-3


 II. EXECUTIVE SUMMARY

  1. INDUSTRY OVERVIEW                                                  II-1
      Remote Patient Monitoring (RPM) - A Transformation Model for
       Health Care Delivery                                             II-1
      Benefits for Patients, Physicians, & Payer                        II-2
       Improved Patient Outcomes and Promoting Self-Care                II-2
       Resource Optimization and Savings - A Key Benefit                II-2
       Payer Benefits                                                   II-3
      Peek into Key Market Growth Drivers                               II-3
       Focus on Healthcare Economics Grows as Healthcare
        Expenditures Rise Globally                                      II-4
        Table 1: Global Healthcare Spending (in US$ Trillion):
        2013-2018 (includes corresponding Graph/Chart)                  II-5

        Table 2: Healthcare Expenditure as a % of GDP Across Select
        Countries (includes corresponding Graph/Chart)                  II-6

        Table 3: Elderly Healthcare Expenditure as a % of GDP
        (includes corresponding Graph/Chart)                            II-7
       Aging Population Creates High Demand                             II-7
        Table 4: Ageing (65+) Demographics as % of Total Population
        by Country (2000, 2011, 2020) (includes corresponding
        Graph/Chart)                                                    II-8
       Chronic Disease Management Presents Huge Market Opportunity      II-8
        Table 5: World Market for Telehealth: Patient Distribution
        (in %) by Disease Condition (includes corresponding
        Graph/Chart)                                                    II-9

        Table 6: Chronic Disease Management in Developed Countries
        (2014): Percentage Distribution of Patient Population by
        Chronic Disease Type in the US, Germany, and the UK
        (includes corresponding Graph/Chart)                            II-10
       Readmission Penalty on Hospitals Provides Impetus to RPM         II-10
        Patient Non-Adherence to Prescribed Medication Promotes RPM
         Market                                                         II-11
         Table 7: Medication Adherence Rates in the US by Condition
         (2012) (includes corresponding Graph/Chart)                    II-11
       Wearable Devices Help Boost RPM Adoption                         II-12
       Venture Capitalists Keen to Fund RPM Technology Companies        II-13
        Table 8: Digital Health Venture Funding in the US
        (2011-2014) (includes corresponding Graph/Chart)                II-14

        Table 9: US Digital Health Venture Capital Funding by
        Category (in %): 2014 (includes corresponding Graph/Chart)      II-14
      Market Issues and Challenges                                      II-15
       High Cost of Remote Patient Monitoring Systems                   II-15
       Lack of Reimbursement                                            II-15
       Patient Privacy Concerns                                         II-15
       Small Practices Challenged by Remote Monitoring Programs         II-16
       Security Issues of Medical Devices                               II-16
      Competitor Landscape                                              II-17
       Table 10: Leading Players in the Global Remote Patient
       Monitoring Market: Percentage Breakdown of Market Share for
       Boston Scientific, GE Healthcare, Medtronic, Philips
       Healthcare, St. Jude Medical, and Others (includes
       corresponding Graph/Chart)                                       II-17

  2. MARKET TRENDS/ISSUES                                               II-18
      Big Data Management Crucial for Effective RPM                     II-18
      Internet of Things (IoT) - Crucial for Healthcare                 II-18
       Cloud Computing: Enhancing RPM Adoption                          II-19
      Partnerships Leverage on Mutual Expertise                         II-20
      Will mHealth make Conventional RPM Obsolete?                      II-21
      Wireless Consumer Devices Favored Over Telehealth                 II-22
      Immobile Patients to Gain from Increased Uptake of Remote
       Monitoring Devices                                               II-22
      CVD Continues to Grab Focus for Remote Monitoring                 II-23
       Table 11: Global Annual Medical Cost of CVD in US$ Billion
       (2010-2030) (includes corresponding Graph/Chart)                 II-24

       Table 12: Economic Burden of Cardiovascular Diseases between
       2011 and 2015: Breakdown of Lost Output Value by Income Group
       (includes corresponding Graph/Chart)                             II-24
       Remote Monitoring - New Standard of Care for Patients with CIEDs II-25
      RPM to Reduce Costs Associated with Diabetes Management           II-26
       Table 13: Global Diabetes Mellitus Incidence among Ages 20-79
       (2014E & 2035P): Prevalence (in Millions) and Percentage
       Share by Geographic Region (includes corresponding
       Graph/Chart)                                                     II-27

       Table 14: Top Ten Countries Worldwide with the Highest Number
       of People (in the Age Group 20-79 Years) with DM (in
       Millions): 2014E & 2035P (includes corresponding Graph/Chart)    II-28
      Remote Monitoring for Neurodegenerative Disease Conditions        II-28
      Remote Monitoring of EEG & Treatment Adequacy                     II-29
      Remote Monitoring Crucial for COPD and Asthma Management          II-30
      Rising Significance of Remote Blood Pressure Monitoring
       Benefits Market Adoption                                         II-31
       Table 15: Death Rates Due to Hypertension in Select
       Countries: 2012 (includes corresponding Graph/Chart)             II-32

       Table 16: Percentage Prevalence Rate of High Blood Pressure
       for Patients over 25 Years of Age by Region (1980 and 2013) -
       Africa, America, South East Asia, Europe, Eastern
       Mediterranean, and Western Pacific (includes corresponding
       Graph/Chart)                                                     II-33
      Remote Patient Monitoring for Sleep Apnea                         II-33
       Table 17: Percentage Prevalence of Sleep Apnea in
       Co-Morbidities by Type of Co-Morbidity (includes
       corresponding Graph/Chart)                                       II-34

  3. PRODUCT OVERVIEW                                                   II-35
      Introduction                                                      II-35
       Remote Patient Monitoring vs. Telehealth                         II-35
      Current Monitoring Systems - A Systematic Review                  II-36
      Remote Patient Monitoring - Architecture                          II-36
      Benefits & Challenges of Remote Patient Monitoring Systems        II-38

  4. PRODUCT LAUNCHES/APPROVALS                                         II-39
      Omron Healthcare Launches BP Monitor                              II-39
      ALR Technologies Seeks FDA Approval for New Health-e-Connect
       Feature                                                          II-39
      HTC Launches Monitoring Device HTC Grip                           II-39
      Covidien Receives CE Marking for Nellcor System                   II-39
      Intel-GE Launches Branded Health Harmony RPM Service              II-39
      Dexcom Receives FDA Approval for Dexcom SHARE Device              II-39
      Honeywell Unveils New Version of Genesis DM™                      II-39
      Honeywell Unveils Latest Version of LifeStream™                   II-40
      AMD Introduces Live Streaming Ultrasound Technology               II-40
      Vital Connect Receives FDA Clearance for HealthPatch™ Biosensor   II-40
      OSTAR Healthcare Launches Remote Patient Monitoring System in
       North America                                                    II-40
      Masimo’s Radius-7 Wearable Monitor Receives CE Approval           II-40
      CardioMEMS System Receives FDA Approval                           II-40
      ReliantHeart’s Assist5® Ventricular Assist Device Receives CE
       Certification                                                    II-40
      HealthInterlink Receives 510(k) clearance for Beacon version 2.0  II-41
      Verizon Receives FDA Clearance for Patient Engagement Tool        II-41
      Sensiotec Unveils Version 2.0 of Virtual Medical Assistant®       II-41
      InfoBionic Receives CE Certification for MoMe™ System             II-41
      Baxter Receives CE Marking for VIVIA Hemodialysis System          II-41
      Verizon Launches Remote Patient Monitoring Platform               II-41
      Preventice Receives CE Certification for BodyGuardian®
       Monitoring System                                                II-41
      Sorin’s Smartview System Receives FDA Approval                    II-42
      Healthx Launches Remote Patient Monitoring Platform               II-42
      Tactio Health Group Launches TactioDiabetes                       II-42
      FDA Approves RP-VITA By iRobot Corp. & InTouch Health             II-42

  5. RECENT INDUSTRY ACTIVITY                                           II-43
      Integrity Applications Enters Distribution Agreements with
       Chinese Players                                                  II-43
      Roche and Qualcomm Enter Collaboration                            II-43
      Honeywell Life Care and MobileHelp Expand Collaboration           II-43
      Honeywell HomMed Changes Name to Honeywell Life Care              II-43
      Welch Allyn Acquires HealthInterLink                              II-43
      LabCorp and Envision Healthcare Invest in Vivify Health           II-43
      Vital Connect Enters Partnership with LifeWatch                   II-44
      Aerocrine Collaborates with Microsoft                             II-44
      Preventice and eCardio Diagnostics Enter Strategic Partnership    II-44
      Geneia Acquires Select Rights on ZephyrLIFE From Covidien         II-44
      Healthsense Raises Funding for Remote Patient Monitoring System   II-44
      Maxis Bhd and EWL Announce Partnership for Health Monitoring
       M2M Solution                                                     II-44
      eCardio Signs Agreement with Shandong Yocaly                      II-44
      Medtronic Acquires Cardiocom                                      II-45
      CardioNet Enters Agreement with IMEC & Holst Centre               II-45

  6. FOCUS ON SELECT GLOBAL PLAYERS                                     II-46
      Abbott Laboratories (US)                                          II-46
      Aerotel Medical Systems (Israel)                                  II-46
      AMD Global Telemedicine, Inc. (US)                                II-47
      BIOTRONIK SE & Co. KG (Germany)                                   II-47
      Boston Scientific Corporation (US)                                II-47
      GE Healthcare Ltd. (UK)                                           II-48
      Honeywell Life Care Solutions (US)                                II-48
      Intelesens Ltd. (UK)                                              II-49
      LifeWatch AG (Switzerland)                                        II-49
      Masimo Corporation (US)                                           II-50
      Medtronic Plc (Ireland)                                           II-50
      Mindray North America (US)                                        II-51
      Nihon Kohden Corporation (Japan)                                  II-51
      Omron Healthcare, Inc. (US)                                       II-51
      Philips Healthcare (Netherlands)                                  II-52
      Qualcomm Life, Inc. (US)                                          II-52
      St. Jude Medical Inc. (US)                                        II-53
      Welch Allyn, Inc. (US)                                            II-53

  7. GLOBAL MARKET PERSPECTIVE                                          II-54
      Table 18: World Recent Past, Current & Future Analysis for
      Remote Patient Monitoring Systems by Geographic Region - US,
      Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest
      of World Markets Independently Analyzed with Annual Sales
      Figures in US$ Million for Years 2014 through 2020 (includes
      corresponding Graph/Chart)                                        II-54

      Table 19: World Historic Review for Remote Patient Monitoring
      Systems by Geographic Region - US, Canada, Japan, Europe,
      Asia-Pacific, Latin America, and Rest of World Markets
      Independently Analyzed with Annual Sales Figures in US$
      Million for Years 2007 through 2013 (includes corresponding
      Graph/Chart)                                                      II-55

      Table 20: World 14-Year Perspective for Remote Patient
      Monitoring Systems by Geographic Region - Percentage Breakdown
      of Value Sales for US, Canada, Japan, Europe, Asia-Pacific,
      Latin America, and Rest of World Markets for Years 2007, 2015
      & 2020 (includes corresponding Graph/Chart)                       II-56


 III. MARKET

  1. THE UNITED STATES                                                  III-1
      A.Market Analysis                                                 III-1
        Key Drivers to Remote Patient Monitoring Market                 III-1
        Remote Monitoring Boosted by HRRP                               III-1
        High Life Expectancy Presents Strong Need for RPM               III-2
         Table 21: Population of the US (2010, 2030 & 2050):
         Percentage Breakdown by Age Groups - Under 18, 18-64 years
         & 65+ years (includes corresponding Graph/Chart)               III-2
        US - The Leading Market for Remote Cardiac Monitoring           III-2
         Table 22: CVD in the US: Cardiovascular Disease Prevalence
         in Adults by Gender & Age Group (includes corresponding
         Graph/Chart)                                                   III-3

         Table 23: CVD in the US: Cardiovascular Disease Incidence
         by Gender & Age Group (per 1,000 Adults) (includes
         corresponding Graph/Chart)                                     III-3

         Table 24: Leading Causes of CVD Fatalities in the US:
         Percentage Breakdown of Mortality for Coronary Heart
         Disease, HBP, Heart Failure, Stroke, and Others (includes
         corresponding Graph/Chart)                                     III-3
        Chronic Disease Management - Focus Area for Remote Monitoring   III-4
         Table 25: US Healthcare Spending (2006-2020) (in US$
         Trillion) (includes corresponding Graph/Chart)                 III-5

         Table 26: US Healthcare Market: Total Annual Expenditure in
         US$ Billion by Chronic Disorder/Disease (includes
         corresponding Graph/Chart)                                     III-5
        Diabetes Statistics in the US                                   III-5
         Table 27: Prevalence of Diabetes Mellitus in the US (2013 &
         2035): Number of People with DM (in Thousands) in the 20-79
         Age Group                                                      III-6
        Sleep Apnea in the US                                           III-6
        Rise in COPD Incidence Drives RPM Adoption                      III-7
         Table 28: Chronic Obstructive Pulmonary Disorder (COPD)
         Incidence in US (2014): COPD Prevalence in Millions by Age
         Group (includes corresponding Graph/Chart)                     III-7
        Reimbursement Scenario                                          III-7
        Remote Monitoring Systems with FDA 510(k) Clearance (2014):     III-8
        Product Launches                                                III-8
        Strategic Corporate Developments                                III-11
        Key Players                                                     III-13
      B.Market Analytics                                                III-18
        Table 29: US Recent Past, Current & Future Analysis for
        Remote Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2014 through 2020 (includes
        corresponding Graph/Chart)                                      III-18

        Table 30: US Historic Review for Remote Patient Monitoring
        Systems Analyzed with Annual Sales Figures in US$ Million
        for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-18

  2. CANADA                                                             III-19
      A.Market Analysis                                                 III-19
        Product Launch                                                  III-19
      B.Market Analytics                                                III-20
        Table 31: Canadian Recent Past, Current & Future Analysis
        for Remote Patient Monitoring Systems Analyzed with Annual
        Sales Figures in US$ Million for Years 2014 through 2020
        (includes corresponding Graph/Chart)                            III-20

        Table 32: Canadian Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-21

  3. JAPAN                                                              III-22
      A.Market Analysis                                                 III-22
        Graying Population Spurs Growth of Patient Monitoring Equipment III-22
         Table 33: Japanese Elderly (65+ Years) Population:
         2000-2020 (includes corresponding Graph/Chart)                 III-22
        Key Player - Nihon Kohden Corporation                           III-22
      B.Market Analytics                                                III-23
        Table 34: Japanese Recent Past, Current & Future Analysis
        for Remote Patient Monitoring Systems Analyzed with Annual
        Sales Figures in US$ Million for Years 2014 through 2020
        (includes corresponding Graph/Chart)                            III-23

        Table 35: Japanese Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-24

  4. EUROPE                                                             III-25
      A.Market Analysis                                                 III-25
        Prevalence of Diabetes in Europe: Market Opportunity for CGM
         Devices                                                        III-25
      B.Market Analytics                                                III-26
        Table 36: European Recent Past, Current & Future Analysis
        for Remote Patient Monitoring Systems by Geographic Region -
        France, Germany, Italy, UK, Spain, Russia, and Rest of
        Europe Markets Independently Analyzed with Annual Sales
        Figures in US$ Million for Years 2014 through 2020 (includes
        corresponding Graph/Chart)                                      III-26

        Table 37: European Historic Review for Remote Patient
        Monitoring Systems by Geographic Region - France, Germany,
        Italy, UK, Spain, Russia, and Rest of Europe Markets
        Independently Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-27

        Table 38: European 14-Year Perspective for Remote Patient
        Monitoring Systems by Geographic Region - Percentage
        Breakdown of Value Sales for France, Germany, Italy, UK,
        Spain, Russia, and Rest of Europe Markets for Years 2007,
        2015 & 2020 (includes corresponding Graph/Chart)                III-28

  4a. FRANCE                                                            III-29
       Market Analysis                                                  III-29
        Table 39: French Recent Past, Current & Future Analysis for
        Remote Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2014 through 2020 (includes
        corresponding Graph/Chart)                                      III-29

        Table 40: French Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-30

  4b. GERMANY                                                           III-31
      A.Market Analysis                                                 III-31
        Key Player - Biotronik SE & Co. KG                              III-31
      B.Market Analytics                                                III-32
        Table 41: German Recent Past, Current & Future Analysis for
        Remote Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2014 through 2020 (includes
        corresponding Graph/Chart)                                      III-32

        Table 42: German Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-33

  4c. ITALY                                                             III-34
      A.Market Analysis                                                 III-34
        Product Launch                                                  III-34
      B.Market Analytics                                                III-34
        Table 43: Italian Recent Past, Current & Future Analysis for
        Remote Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2014 through 2020 (includes
        corresponding Graph/Chart)                                      III-34

        Table 44: Italian Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-35

  4d. THE UNITED KINGDOM                                                III-36
      A.Market Analysis                                                 III-36
        Telecare and Elderly Population Requirements - An Overview      III-36
        Self-Monitoring Blood Glucose Meters Gain Popularity            III-37
        Product Approval                                                III-37
        Key Players                                                     III-37
      B.Market Analytics                                                III-39
        Table 45: UK Recent Past, Current & Future Analysis for
        Remote Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2014 through 2020 (includes
        corresponding Graph/Chart)                                      III-39

        Table 46: UK Historic Review for Remote Patient Monitoring
        Systems Analyzed with Annual Sales Figures in US$ Million
        for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-40

  4e. SPAIN                                                             III-41
       Market Analysis                                                  III-41
        Table 47: Spanish Recent Past, Current & Future Analysis for
        Remote Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2014 through 2020 (includes
        corresponding Graph/Chart)                                      III-41

        Table 48: Spanish Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-42

  4f. RUSSIA                                                            III-43
       Market Analysis                                                  III-43
        Table 49: Russian Recent Past, Current & Future Analysis for
        Remote Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2014 through 2020 (includes
        corresponding Graph/Chart)                                      III-43

        Table 50: Russian Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-44

  4g. REST OF EUROPE                                                    III-45
      A.Market Analysis                                                 III-45
        Strategic Corporate Developments                                III-45
        Key Players                                                     III-45
      B.Market Analytics                                                III-47
        Table 51: Rest of European Recent Past, Current & Future
        Analysis for Remote Patient Monitoring Systems Analyzed with
        Annual Sales Figures in US$ Million for Years 2014 through
        2020 (includes corresponding Graph/Chart)                       III-47

        Table 52: Rest of European Historic Review for Remote
        Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2007 through 2013 (includes
        corresponding Graph/Chart)                                      III-48

  5. ASIA-PACIFIC                                                       III-49
      A.Market Analysis                                                 III-49
        Outlook                                                         III-49
        Improving Infrastructure Facilitates RPM Adoption               III-49
        Undiagnosed Diabetic Population Offers Potential for Remote
         Monitoring                                                     III-49
      B.Market Analytics                                                III-50
        Table 53: Asia-Pacific Recent Past, Current & Future
        Analysis for Remote Patient Monitoring Systems by Region -
        China and Rest of Asia-Pacific Markets Independently
        Analyzed with Annual Sales Figures in US$ Million for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-50

        Table 54: Asia-Pacific Historic Review for Remote Patient
        Monitoring Systems by Region - China and Rest of
        Asia-Pacific Markets Independently Analyzed with Annual
        Sales Figures in US$ Million for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-51

        Table 55: Asia-Pacific 14-Year Perspective for Remote
        Patient Monitoring Systems by Region - Percentage Breakdown
        of Value Sales for China and Rest of Asia-Pacific Markets
        for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-52

  5a. CHINA                                                             III-53
      A.Market Analysis                                                 III-53
        Large Population Results in Quicker RPM Adoption                III-53
         Table 56: Healthcare Expenditure in China as a % of GDP
         (2006-2015) (includes corresponding Graph/Chart)               III-54

         Table 57: Percentage of Population Aged 65 and Above in
         China (2000-2020) (includes corresponding Graph/Chart)         III-54

         Table 58: Incidence of Chronic Diseases in China (2014)
         (includes corresponding Graph/Chart)                           III-54
        China: An Untapped Goldmine for Blood Glucose Monitoring
         Devices                                                        III-55
        Strategic Corporate Development                                 III-55
      B.Market Analytics                                                III-56
        Table 59: Chinese Recent Past, Current & Future Analysis for
        Remote Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2014 through 2020 (includes
        corresponding Graph/Chart)                                      III-56

        Table 60: Chinese Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-56

  5b. REST OF ASIA-PACIFIC                                              III-57
      A.Market Analysis                                                 III-57
        India: Remote Patient Monitoring Gains Popularity               III-57
        Rising Diabetic Populace Spurs Growth in Remote Glucose
         Monitoring Devices                                             III-57
        Strategic Corporate Development                                 III-58
      B.Market Analytics                                                III-59
        Table 61: Rest of Asia-Pacific Recent Past, Current & Future
        Analysis for Remote Patient Monitoring Systems Analyzed with
        Annual Sales Figures in US$ Million for Years 2014 through
        2020 (includes corresponding Graph/Chart)                       III-59

        Table 62: Rest of Asia-Pacific Historic Review for Remote
        Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2007 through 2013 (includes
        corresponding Graph/Chart)                                      III-60

  6. LATIN AMERICA                                                      III-61
       Market Analysis                                                  III-61
        Table 63: Latin American Recent Past, Current & Future
        Analysis for Remote Patient Monitoring Systems by Region -
        Brazil and Rest of Latin American Markets Independently
        Analyzed with Annual Sales Figures in US$ Million for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-61

        Table 64: Latin American Historic Review for Remote Patient
        Monitoring Systems by Region - Brazil and Rest of Latin
        American Markets Independently Analyzed with Annual Sales
        Figures in US$ Million for Years 2007 through 2013 (includes
        corresponding Graph/Chart)                                      III-62

        Table 65: Latin American 14-Year Perspective for Remote
        Patient Monitoring Systems by Region - Percentage Breakdown
        of Value Sales for Brazil and Rest of Latin American Markets
        for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-63

  6a. BRAZIL                                                            III-64
       Market Analysis                                                  III-64
        Table 66: Brazilian Recent Past, Current & Future Analysis
        for Remote Patient Monitoring Systems Analyzed with Annual
        Sales Figures in US$ Million for Years 2014 through 2020
        (includes corresponding Graph/Chart)                            III-64

        Table 67: Brazilian Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-65

  6b. REST OF LATIN AMERICA                                             III-66
       Market Analysis                                                  III-66
        Table 68: Rest of Latin American Recent Past, Current &
        Future Analysis for Remote Patient Monitoring Systems
        Analyzed with Annual Sales Figures in US$ Million for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-66

        Table 69: Rest of Latin American Historic Review for Remote
        Patient Monitoring Systems Analyzed with Annual Sales
        Figures in US$ Million for Years 2007 through 2013 (includes
        corresponding Graph/Chart)                                      III-67

  7. REST OF WORLD                                                      III-68
      A.Market Analysis                                                 III-68
        Key Player - Aerotel Medical Systems (Israel)                   III-68
      B.Market Analytics                                                III-69
        Table 70: Rest of World Recent Past, Current & Future
        Analysis for Remote Patient Monitoring Systems Analyzed with
        Annual Sales Figures in US$ Million for Years 2014 through
        2020 (includes corresponding Graph/Chart)                       III-69

        Table 71: Rest of World Historic Review for Remote Patient
        Monitoring Systems Analyzed with Annual Sales Figures in US$
        Million for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-70


 IV. COMPETITIVE LANDSCAPE

     Total Companies Profiled: 83 (including Divisions/Subsidiaries - 85)

     The United States (55)
     Canada (6)
     Japan (1)
     Europe (16)
     - Germany (3)
     - The United Kingdom (4)
     - Italy (1)
     - Rest of Europe (8)
     Asia-Pacific (Excluding Japan) (4)
     Middle East (3)
Additional Information:
This report is offered in PDF format via e-mail. Once downloaded, the PDF can’t be copied to another computer. The user is permitted to print one full copy of the report. Extra copies or licenses may be purchased at 10% of the list price.
Date of Publication:
Sep 18, 2015
File Format:
PDF via E-mail
Number of Pages:
273 Pages
Type the characters you see in the picture above.